Brand name arakoda malaria prophylactic drug tafenoquine

Ended Definitive Contract Awarded Last action

Contract number
W81XWH19C0181
Awardee
Awarding agency
Obligated
$5,473,597

Award facts

Opportunity
Contract value 92% obligated
  • $5,473,596.82 Current, with exercised options
  • $5,971,271.82 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Funding agency
Medical Command Department of the Army, Department of Defense
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Washington, DC 20036, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00008 -$28,966
Novation Agreement P00007 · Brand name arakoda tafenoquine $0
Exercise an Option P00006 · Brand name arakoda tafenoquine storage exercise options 3005, 3006 and 4002. $69,450
Exercise an Option P00005 · Brand name arakoda tafenoquine - exercise option clin 3001. $1,068,750
Supplemental Agreement for work within scope P00004 · Incorporate far clause 52.204-25 prohibition on contracting with entities usingcertain telecommunications and video surveillance services or equipment. $0
Supplemental Agreement for work within scope P00003 · Brand name arakoda tafenoquine MOD P000003 exercises option contract line item number (CLIN) 2001. $1,068,750
Supplemental Agreement for work within scope P00002 · MOD P00002 incorporates new clins: 1002, 1003, 1004, 2002, 2003, 2004, 2005, 3002, 3003, 3004, 3005 3006 2007, 2008, 2009, 2010 4001, 4002, 4003, 4004, 4005,… $89,363
Exercise an Option P00001 · Brand name arakoda tafenoquine MOD P00001 exercises clin 1001 $1,068,750
Original award $2,137,500

About this award

Written by GovTribe AI ·

This is a $5,971,271.82 definitive contract awarded by the U.S. Army Medical Command to 60 Degrees Pharmaceuticals, Inc. for the brand name malaria prophylactic drug Tafenoquine, marketed as Arakoda. The contract is a firm fixed price award with no set-aside designation. The original solicitation was a request for information (RFI) seeking entities interested in providing an initial commercial lot of approximately 120,000 Arakoda tablets, with options for up to three additional lots of 7,500 packages each. This contract supports the U.S. Army Medical Materiel Development Activity's Combat Trauma and Acute Rehabilitation Program. 60 Degrees Pharmaceuticals is a specialty pharmaceutical company that develops and commercializes infectious disease medicines, and holds multiple indefinite delivery vehicle (IDV) contracts with the Department of Veterans Affairs for pharmaceutical procurement.

Quick answers

Who was awarded contract W81XWH19C0181?

W81XWH19C0181 was awarded to 60 Degrees Pharmaceuticals, Inc. by Defense Health Agency (Department of Defense) on September 1, 2019.

How much is contract W81XWH19C0181 worth?

The government has obligated $5,473,597 on W81XWH19C0181. Its potential value, with all options, is $5,971,272.

Which agency awarded contract W81XWH19C0181?

Defense Health Agency (Department of Defense) awarded W81XWH19C0181, with funding from Medical Command (Department of the Army).

Was contract W81XWH19C0181 competed?

The extent of competition for W81XWH19C0181 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login